Alkaloids: about 5 g of powdered drug was boiled in dilute hydrochloric acid. It was filtered and made alkaline by the addition of dilute ammonia solution. This alkalinized solution was extracted with 5 mL of chloroform. The chloroform layer was then extracted with 10 mL dilute acetic acid. To the acetic acid extract, few drops of Dragendorff's reagent was added (Orange precipitate or turbidity indicate the presence of alkaloids).
Braemer's test for tannins: 5 g of drug was extracted with methanol. To methanolic extract, 10%alcoholic ferric chloride solution was added. Dark blue or greenish grey coloration of the solution indicates the presence of tannins in the drug.
Saponins: 5 g of powdered drug was vigorously shaken with water and noted for production of froth (persistent froth for 20 min indicates the presence of saponins).
Borntrager's test for free anthraquinones: 5 g of powdered drug was extracted with hot water and filtered while hot. On cooling, it was extracted with carbon tetrachloride. The carbon tetrachloride was separated and washed with water and shaken with dilute ammonia solution (pink to cherry-red color in ammonia layer indicate the presence of free anthraxquinones).
Modified Borntrager's test for bound anthraquinones: 5 g of powdered drug was extracted with ferric chloride solution and hydrochloric acid. It was heated on water bath for 10 min and filtered while hot. On cooling, it was extracted with carbon tetrachloride. The carbon tetrachloride was separated and washed with water and shaken with dilute ammonia solution color (intense pink to cherry-red coloration of ammonia layer indicate the presence of anthraquinones glycosides).
Shinoda test for flavonoids: 5 g of drug was extracted with methanol. To methanol extract, a piece of magnesium ribbon and 1 ml of concentrated hydrochloric acid were added. (Pink red or red coloration of the solution indicate the presence of flavonoids in the drug).
In vitro α-glucosidase inhibition assay:
The α-glucosidase inhibitory activity was assessed by the standard method (Dong et al., 2012) with slight modifications. Briefly, a volume of 60 µL of sample solution and 50 µL of 0.1 M phosphate buffer (pH 6.8) containing α-glucosidase solution (0.2 U/mL) was incubated in 96 well plates at 37 ºC for 20 min. After pre-incubation, 50 µL of 5 mM p-nitrophenyl-α-D-glucopyranoside (PNPG) solution in 0.1 M phosphate buffer (pH 6.8) was added to each well and incubated at 37 ºC for another 20 min. Then the reaction was stopped by adding 160 µL of 0.2 M NaCO3 into each well, and absorbance readings (A) were recorded at 405 nm by micro-plate reader and compared to a control which had 60 µL of buffer solution in place of the extract. For blank incubation (to allow for absorbance produced by the extract), enzyme solution was replaced by buffer solution and absorbance recorded. The concentrations of test compounds which inhibited the hydrolysis of substrates (butyrylthiocholine) by 50% (IC50) were determined by monitoring the effect of increasing concentrations of these compounds in the assays on the inhibition values (Rehman et al., 2013 ). The IC50 values were then calculated using the EZ-Fit Enzyme Kinetics program (Perrella Scientific Inc., Amherst, USA).
In vivo antidiabetic study
Animal selection and treatment: 30 male rabbits each of weighing 1-1.5 kg were used and all rabbits were checked for evidence of any infections. All the rabbits were housed in the animal house of the Department of Pharmacy B.Z.U Multan. They were housed in the steel cages under standard laboratory condition (light period 8:00 am to 8:00 pm 21± 2 °C, relative humidity 55%, green fodder and water was available as labatum). The protocol was approved by Ethical Committee of Department of Pharmacy Bahauddin Zakariya University Multan. Groups were control (non-diabetic), control group (received vehicle only, diabetic), alloxan induced diabetic rabbits treated with C. lancifolius 100 mg/kg, alloxan induced diabetic rabbits treated with C. lancifolius 200 mg/kg, and alloxan-induced diabetic rabbits treated with diamicron 80 mg/kg (Hader et al., 1994) .
Induction of diabetes:
Animals were devided into five experimental groups (control, diabetic, diabetic treated with 100 mg/kg body weight C. lancifolius diabetic treated with 200 mg/kg body weight, C. lancifolius and diabetic treated with diamicron 80 mg/kg) Each group contained six rabbits. Before starting experiment the animals in latter four groups were injected. 150 mg/kg of alloxan (sigma chemical co,) dissolved in 10% isotonic saline to induce diabetes (Issa et al., 2000) . The alloxan is selective beta-cells cytotoxic drug. It produced all signs and symptoms of diabetes. i.e. hyperglycemia, glycosuria, polydipsia, polyurea, etc. The control group was injected the same volume of isotonic solution as that of diabetic received. The blood glucose level of surviving rabbits was checked after three days of Alloxan injection and rabbits with blood glucose level more than 250 mg/dL on 12 hours fasting were considered as diabetics (Fridewald et al., 1979) .
The last two groups were given the C. lancifolius extract, i.e. Group 1 received 100 mg/kg C. lancifolius extract daily for 30 days; Group 2 received 200 mg/kg C. lancifolius extract daily for 30 days.
Biochemical analysis:
The plasma glucose levels were measured, using a glucose oxidase kit (Accu Check Advantage Rosche Chemicals Switzerland). The plasma total cholesterol, triglyceride, HDL, and ALT & AST levels were evaluated by enzymatic test kits (Randox). LDL level was calculated by using following formula:
Creatinin clearance was determined with the help of Chemistry analyzer Micro Lab 200 (Merck).
Statistical analysis:
The experimental results were expressed as mean ± standard deviation (SD) of three replicates. The data were subjected to one way analysis of variance (ANOVA) Turkey's Test was used to test for differences among Means for which ANOVA indicated a significant.
Results and Discussions
The phytochemical screening of arial part of C. lancifolius is shown in Table I . In vitro α-glucosidase inhibitory activities of the plant extracts aforementioned are summarized in Table II . Methanol extract possessed excellent α-glucosidase inhibitory activity even at low concentration. Methanol extract studied showed the most potent inhibitory activity 99.8% with IC50 found to be 14.9 mg/mL compared to the standard (acorbose) which exhibited 92.2%inhibition with IC50 found to be 14.9 mg/mL inhibition on α-glucosidase. Table III shows the antidiabetic effect of C. lancifolius treated (100 mg/kg and 200 mg/kg) as compared to treated with 80 mg/kg diamicron, control and diabetic. Blood glucose concentration of diabetic rabbits 269.2 ± 5.8 mg/dL (mean ± SD) was increased significantly (p≤0.05) as compared to the control group. In control group level of blood glucose was 93.2 ± 5.4 mg/dL. Treatment with methanolic extract 200 mg/kg of C. lancifolius significantly decreased the blood glucose levels of diabetic treated group with mean value 136.0 ± 3.15 mg/dL (p<0.05) and their glucose levels were within normal range (75-150 mg/dL). Diamicron has no significant effect (226.2 ± 4.1 mg/dL) as compared with C. lancifolius methanol extract (136 ± 3.1 mg/dL). (Chatila and West, 1996) which itself re-presents a huge and rapidly increasing problem. Liver and kidney glutathione levels have been reported to decrease in experimental diabetic rats (Loven et al., 1986 The effect of C. lancifolius extract in alloxan-induced diabetic rabbits on creatinine clearance. Because chronic diabetes mellitus causes renal failure (Sacks, 1997) .
Creatinine clearance mg/dL values were not significantly (p≤0.05) changed in diabetic rabbits.
Blood urea level of diabetic rabbits is not significantly increased and treatment with C. lancifolius has not significant effect on blood urea and creatinine concentration.
Diabetes mellitus is a chronic disorder of metabolism caused by an absolute or relative lack of insulin. It is characterized by hyperglycemia in postprandial and fasting state, and its severe form is accompanied by ketosis and protein wasting (Athanasakis et al., 2010) .
Diabetes is one of the world's greatest health problems, affecting about 171 million people and most of these will be dominated by those suffering from type II diabetes (Moller, 2001 ).
In diabetes mellitus there is heterogencity, so need for appropriate therapy increased. There is a use of traditional medicinal plants to overcome the complications of diabetes (Alamgeer et al., 2013) . Our studies offer a natural key to unlock the complications in future. α-glucosidase inhibitor inhibits the disaccharide digestion and impedes the postprandial glucose excursion to enable overall smooth glucose profile (Casirola and Ferraris, 2006) . Thus, natural products of great structural diversity are still a good source for searching for such inhibitors, thereby motivating to explore biologically active compounds from the highly diverse plants.
The aim of this study was to asses to antihyperglycemic effect of C. lancifolius in transiently hyperglycemic rabbits. The dose expressed in mg/kg administered of C. lancifolius is different because the traditional way for preparations and volume/kg of administration was used. Studies shows that diabetes causes the abnormallities in lipids, carbohydrate and protein metabolism.
Differences in social structure, psychic stress, obesity, hormonal imbalance and heredity are optimizing the growth of pandemic. At present, the treatment of diabetes mainly involves a sustained reduction in hyperglycemia by the use of biguanides, thiazolidinediones, sulphonylureas, D-phenylalanine derivatives, meglitinides and α-glucosidase inhibitors in addition to insulin. However, due to unwanted side effects the efficacies of these compounds are debatable and there is a demand for new compounds for the treatment of diabetes (Oubre et al., 1997) . Hence, plants have been suggested as a rich, as yet unexplored source of potentially useful antidiabetic drugs. However, only a few have been subjected to detailed scientific investigation due to a lack of mechanism-based available in vitro assays (Bell, 1991) . These efforts may provide treatment for all and justify the role of novel traditional medicinal plants having anti-diabetic potentials. The methanolic extract also prevents body weight loss in diabetic rabbits.
The present study provides the evidence that the methanolic extract of C. lancifolius have prominent antidiabetic potential due to gluconeogenesis supperssion in alloxan induced diabetic rabbits may be due to saponins contents of C. lancifolius.
